ReviewJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance2013
Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance.
Review in Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03935282 (Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors), which is not on this map. Cited by 30 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors (AH-HA)
Who cites it
30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.
- Association between Statin Use and Chemotherapy-Induced Cardiotoxicity: A Meta-Analysis.Medicina (Kaunas, Lithuania) · 2024Pooled it
- Aromatase inhibitors and risk of cardiovascular events in breast cancer patients: a systematic review and meta-analysis.BMC pharmacology & toxicology · 2019Pooled it
- Chinese guideline for the clinical application of noninvasive imaging technology in accessing cancer therapy-related cardiovascular toxicity.Journal of geriatric cardiology : JGC · 2025Article
- Quantitative assessment of radiotherapy-induced myocardial damage using MRI: a systematic review.Cardio-oncology (London, England) · 2023Review
- Toward a Better Understanding of the Differential Impact of Heart Failure Phenotypes After Breast Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022Article
- Perioperative mortality of head and neck cancers.BMC cancer · 2021Article
- Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative.The oncologist · 2020Observational
- The Role of Cardiac MRI in Animal Models of Cardiotoxicity: Hopes and Challenges.Journal of cardiovascular translational research · 2020Review
- Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.Annals of oncology : official journal of the European Society for Medical Oncology · 2020Article
- Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies.Journal of the American Heart Association · 2020Review
- Simultaneous Left Ventricular Volume and Strain Changes During Chemotherapy Associate With 2-Year Postchemotherapy Measures of Left Ventricular Ejection Fraction.Journal of the American Heart Association · 2020Article
- Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors.Heart failure reviews · 2019Review
- Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer.Journal of thrombosis and haemostasis : JTH · 2019Observational
- Frequency of Transition From Stage A to Stage B Heart Failure After Initiating Potentially Cardiotoxic Chemotherapy.JACC. Heart failure · 2018Article
- Cardiovascular imaging in cardio-oncology.Journal of thoracic disease · 2018Review
- Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer.Haematologica · 2018Article
- Cardiovascular Magnetic Resonance in the Oncology Patient.JACC. Cardiovascular imaging · 2018Review
- The risk of cardiovascular disease following breast cancer by Framingham risk score.Breast cancer research and treatment · 2018Article
- In Vivo Reactive Oxygen Species Detection With a Novel Positron Emission Tomography Tracer,JACC. Basic to translational science · 2018Article
- The Role of Cardiovascular Magnetic Resonance in the Management of Patients with Cancer.Current treatment options in cardiovascular medicine · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
While cancer-free survival has improved over the past 20 years for many individuals with prostate, renal, breast, and hematologic malignancies, the increasingly recognized prevalence of cardiovascular (CV) events in cancer survivors has been an unintended consequence of many of the therapies that have improved these survival rates. The increase in CV events threatens to offset the improvement in cancer related survival. As a result, there is an emerging need to develop methods to identify those individuals treated for cancer at increased risk of cardiovascular events. With its inherent ability to characterize myocardial tissue and identify both cardiac and vascular dysfunction, cardiovascular magnetic resonance (CMR) has the potential to identify both subclinical and early clinical CV injury before the development of an overt catastrophic event such as a myocardial infarction, stroke, or premature cardiac death. Early identification provides an opportunity for the implementation of primary prevention strategies to prevent such events, thereby improving overall cancer survivorship and quality of life. This article reviews the etiology of CV events associated with cancer therapy and the unique potential of CMR to provide early diagnosis of subclinical CV injury related to the administration of these therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.